- Home
- DERM vs NXG Comparison
DERM vs NXG Comparison
Compare DERM & NXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- NXG
- Stock Information
- Founded
- DERM 2014
- NXG 2012
- Country
- DERM United States
- NXG United States
- Employees
- DERM N/A
- NXG N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- NXG
- Sector
- DERM Health Care
- NXG
- Exchange
- DERM Nasdaq
- NXG Nasdaq
- Market Cap
- DERM 174.7M
- NXG 163.3M
- IPO Year
- DERM 2021
- NXG N/A
- Fundamental
- Price
- DERM $6.88
- NXG $46.22
- Analyst Decision
- DERM Strong Buy
- NXG
- Analyst Count
- DERM 2
- NXG 0
- Target Price
- DERM $10.00
- NXG N/A
- AVG Volume (30 Days)
- DERM 78.2K
- NXG 24.4K
- Earning Date
- DERM 05-20-2025
- NXG 01-01-0001
- Dividend Yield
- DERM N/A
- NXG 14.78%
- EPS Growth
- DERM N/A
- NXG N/A
- EPS
- DERM N/A
- NXG N/A
- Revenue
- DERM $56,134,000.00
- NXG N/A
- Revenue This Year
- DERM $29.83
- NXG N/A
- Revenue Next Year
- DERM $54.88
- NXG N/A
- P/E Ratio
- DERM N/A
- NXG N/A
- Revenue Growth
- DERM N/A
- NXG N/A
- 52 Week Low
- DERM $3.20
- NXG $30.32
- 52 Week High
- DERM $7.84
- NXG $42.29
- Technical
- Relative Strength Index (RSI)
- DERM 52.73
- NXG 58.37
- Support Level
- DERM $6.47
- NXG $42.78
- Resistance Level
- DERM $7.15
- NXG $46.94
- Average True Range (ATR)
- DERM 0.49
- NXG 1.19
- MACD
- DERM -0.09
- NXG 0.50
- Stochastic Oscillator
- DERM 37.25
- NXG 88.61
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About NXG NXG NextGen Infrastructure Income Fund of Beneficial Interest
Cushing NextGen Infrastructure Income Fund is a closed-end investment management company. Its investment objective is to seek a high total return with a focus on current income. The Fund invests at least 80% of its net assets in a portfolio of equity and debt securities of infrastructure companies, including energy infrastructure companies, industrial infrastructure companies, sustainable infrastructure companies, and technology & communication infrastructure companies.